Hyde V2 Cherry Bomb
ProSupps USA LLC recalled this product and the FDA reported the enforcement action on 11 October 2017 as Class II. The recall was initiated by the firm. Product contains the unapproved ingredient, picamilon.
The record
Every field below is published by the FDA in the openFDA food enforcement database. Check the FDA notice before acting on any recall: this page is a reading of the public record, not a substitute for it.
- Product
- Hyde V2 Cherry Bomb
- Reason for recall
- Product contains the unapproved ingredient, picamilon.
- Recalling firm
- ProSupps USA LLC
- Firm location
- Plano, Texas, United States
- Classification
- Class II
- Status
- Terminated
- Recall number
- F-3594-2017
- Quantity
- 4483 units
- Distribution
- US and Canada
- Initiated
- 30 August 2017
- Reported by FDA
- 11 October 2017
- Terminated
- 6 February 2018
- Firm notified by
- Letter
- Product codes
- A109101215, XA105220815
Reading this record
Five things about this record are not in the record itself, and each one changes how it should be read.
- Class II means the FDA judged a remote probability of serious harm, or a probability of temporary or medically reversible harm. The class is assigned by an agency health hazard evaluation under 21 CFR 7.41, not by the firm.
- The firm started this recall itself. Most FDA food recalls are voluntary, and a recall is a food safety plan working rather than failing. The circumstances in which the agency asks for one instead are set out in 21 CFR 7.45.
- This is one of 18 records covering the same recall event. The FDA opens one enforcement record per product code, so a recall of a product line appears here many times. Counting these records as 18 separate recalls, which almost every published figure does, overstates it by a factor of 18. Every product code in this event is listed together on the record that covers the whole recall, which is the page a search engine is pointed to for all 18 of them.
- The recall ran for 5 months, from 30 August 2017 to termination on 6 February 2018. Termination means the agency judged that all reasonable effort had been made, under 21 CFR 7.55, and it says nothing about whether product remained in circulation.
- The FDA published the enforcement report 6 weeks after the firm began the recall.
- The product description on this record names no food this site can classify, so it appears on no food-type page. That is a limit of the description rather than of the recall.
What this recall was for
Unapproved ingredients
An unapproved ingredient recall means a product contained a substance not permitted in food, most often an undisclosed pharmaceutical active found in a dietary supplement.
A preventive controls plan covers an unapproved ingredient under the clauses below. This is where the control belongs, not a finding against any firm named on this page: a recall record states a reason, and most of these recalls were initiated by the firm itself.
- 21 CFR 111
- Dietary supplement CGMP: the identity, purity, strength and composition specifications a supplement manufacturer sets and verifies for every component and finished batch.
- 21 CFR 117 subpart G
- Supply-chain programme: the approval and verification a receiving facility runs on a supplier when the hazard is controlled before the ingredient arrives.
Other records from ProSupps USA LLC
The FDA opens one enforcement record per product code, so several of these are frequently one recall event. 31 other records name this firm.
All 32 records for ProSupps USA LLC
All 2017 recalls · All FDA food recall data
21 CFR 111 is the clause behind this recall, and it is one somebody has to produce evidence for at their next audit. Krolda maps supplier documents to the clause they satisfy in FSSC 22000, IFS Food and 21 CFR 117, and routes the corrective action when the evidence is missing.
Early accessRecall records come from the openFDA food enforcement API, published by the U.S. Food and Drug Administration in the public domain. Krolda adds the hazard classification and the clause mapping; neither is an FDA determination. Always check the FDA notice before acting on a recall.